Crowdonomics
This isn’t PhorMed’s most recent raise. Reg CF · Common Stock · Oct 2023 (Closed) is more current.View latest round
PhorMed

Reg CF · Common Stock · May 2022

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$170K / $2.2M max
8% of ceiling · target hit day 5
Investors
207
$1.2K avg
Post-money valuation
$51.8M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$247K$124K$0
2121060
May 17, 2022 · openedAug 18, 2022 · last reading
Target ($10K) hit — May 22, 2022, day 5Deadline Aug 17, 2022

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
$948K
FY2020
$0
−$574K
FY2021
RevenueNet income
Metric
FY2020
FY2021 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$948,160
-$573,584
Taxes paid
$0
$0
Balance sheet
Cash
$109,844
$105,694
Accounts receivable
$0
$0
Total assets
$340,922
$183,724
Short-term debt
$363,294
$227,264
Long-term debt
$0
$0
Total liabilities
$363,294
$227,264
Other
Headcount
7
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$51.6M
Post-money$51.8M
Price / share$1.00
Shares offered10,000

Perks

Invest within the first week and receive 20% bonus shares · until May 23, 202220% bonus

Offering details

Target$10,000
Max$2,150,494
Min investment$500
OpenedMay 17, 2022
DeadlineAug 17, 2022
ClosedAug 17, 2022
Days active92

Links & provenance

Source: Manual
0001665160-22-001674
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.